Search
for
Sort by
Research 30 of 734
- S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders
- What are the possible reasons for urethral PSA varieties after radical prostatectomy?
- 5ARIs and PSA: Evidences
- Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
- Level-1 Data From the REDUCE Study and the PCPT Data
- S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION?
- S2 PSA: RELIABLE OR NOT RELIABLE?
- 1746 INCREASED SERUM C-REACTIVE PROTEIN LEVELS IMPLIES CHRONIC INFLAMMATION IS INVOLVED IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PREDOMINANT STORAGE LOWER URINARY TRACT SYMPTOMS
- Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome
- Serum prostate spesific antigen levels in women with androgenetic alopecia
- Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- Role of serum androgens and prostate-specific antigen levels in males with androgenetic alopecia
- P152 : Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL
- Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study